Users frequently report feeling younger and more vital after extended protocols, with improvements in energy, mobility, and resilience that suggest genuine tissue rejuvenation rather than simple symptom management
However, the robustness of the evidence differs markedly: data are extensive for obesity, more limited and heterogeneous for BED, and extremely sparse for BN
[33] broadened the scope to 26 studies ( n = 3,020), including both metabolic RCTs with secondary psychiatric outcomes and a small number of trials in clinical populations (e.g., substance use disorders)
Dose escalation over 16 weeks
The effectiveness and safety of exenatide versus metformin in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials
Insights into the regulation of mitochondrial functions by protein kinase A-mediated phosphorylation